These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3218277)

  • 1. [Drugs--between empirical and rational use].
    Oehme P
    Z Gesamte Inn Med; 1988 Nov; 43(22):630-4. PubMed ID: 3218277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The physician as medication. Relationship effects in pharmaceutical medicine as exemplified by the placebo].
    Grob P
    Schweiz Rundsch Med Prax; 1989 Feb; 78(8):180-5. PubMed ID: 2922512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of clinical psychiatry in the development of new drugs].
    Benkert O; Hippius H
    Arzneimittelforschung; 1975 Jul; 25(7a):1195-206. PubMed ID: 1242348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The nameless pill. The effects and side-effects of the therapeutic use of placebo preparations].
    Piechowiak H
    Schweiz Med Wochenschr; 1981 Aug; 111(34):1222-32. PubMed ID: 7280632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo and its importance in medicine.
    Vrhovac B
    Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):161-5. PubMed ID: 870439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sociopharmacology--psychoactive drugs as an example].
    Fisch HU
    Schweiz Med Wochenschr; 1979 Mar; 109(13):461-6. PubMed ID: 432578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in pediatric pharmacology, therapeutics, and toxicology.
    Berlin CM
    Adv Pediatr; 2001; 48():439-64. PubMed ID: 11480767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-ranging in clinical trials: rationale and proposed use with placebo or positive controls.
    Freston JW
    Am J Gastroenterol; 1986 May; 81(5):307-11. PubMed ID: 3706243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some aspects of pharmacotherapy in the context of transference-countertransference].
    Jakubczyk A; Murawiec S; Zechowski C
    Psychiatr Pol; 2004; 38(6):1115-25. PubMed ID: 15779675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The present status of research and development of original drugs].
    Kuchar M
    Cas Lek Cesk; 1998 May; 137(11):323-9. PubMed ID: 9727205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-metabolism research challenges in the new millennium: individual variability in drug therapy and drug safety.
    Lu AY
    Drug Metab Dispos; 1998 Dec; 26(12):1217-22. PubMed ID: 9860931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The placebo problem].
    Reinhard W
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():35S-39S. PubMed ID: 7321658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The placebo: beyond pretense and the nuisance variable. Arguments in favor of re-evaluating a significant protherapeutic concept ("aura curae")].
    Langer G
    Wien Klin Wochenschr Suppl; 1987; 175():1-20. PubMed ID: 3318149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical trial of drugs (2): principles and problems].
    Janson J; Johnsson G; Sölvell L
    Lakartidningen; 1970 Jun; 67():Suppl II:44+. PubMed ID: 4920749
    [No Abstract]   [Full Text] [Related]  

  • 19. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The place of a new drug in the therapeutic strategy].
    Castaigne A; Goehrs JM; Ravoire S
    Therapie; 1999; 54(4):463-70. PubMed ID: 10667112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.